Received Aug 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | — | — |
a Menveo 1 vial vaccination was given instead of Bexsero; This non-serious case was reported by a nurse via call center representative and described the occurrence of wrong vaccine administered in a 22-year-old female patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis. Co-suspect products included Men B NVS (Bexsero) for prophylaxis. On 21-JUL-2025, the patient received Menveo. The patient did not receive Bexsero. On 21-JUL-2025, an unknown time after receiving Menveo, the patient had wrong vaccine administered (Verbatim: a Menveo 1 vial vaccination was given instead of Bexsero). The outcome of the wrong vaccine administered was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 20-AUG-2025 Nurse practitioner called to report that a Menveo 1 vial vaccination was given instead of Bexsero, which led to wrong vaccine administered. The reporter needed further guidance on this situation. The vaccine administration facility was the same as primary reporter.